Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Raval

Showing results (81-90 of 91) with videos related to

Pageof 10
Sort By:
Journal of Neuro-Oncology|June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysisJoshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Frontiers in Oncology|December 12, 2022
Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapyKhaled Dibs, Joshua D Palmer, Rahul N Prasad, et al.
Neuro-Oncology|May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoterMichael Lim, Michael Weller, Ahmed Idbaih, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2025
Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy: A Single Institution Analysis of 534 Resected MetastasesHaley K Perlow, Sarah Hennings, Jared Bradshaw, et al.
International Journal of Obesity (2005)|August 5, 2015
A novel gene THSD7A is associated with obesityS Nizamuddin, P Govindaraj, S Saxena, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Improved progression-free survival following dose-escalated vs. standard dose post-operative radiation therapy for high-risk meningiomas: An International Multicenter Individual Patient Level Meta-Analysis (FIRESTORM)Raj Singh, Andrew Koempel, Beck French, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Pageof 10

Showing results (81-90 of 91) with videos related to

Sort By:
Pageof 10
Journal of Neuro-Oncology|June 25, 2022
Fractionated pre-operative stereotactic radiotherapy for patients with brain metastases: a multi-institutional analysisJoshua D Palmer, Haley K Perlow, Jennifer K Matsui, et al.
Frontiers in Oncology|December 12, 2022
Feasibility, safety, and efficacy of circumferential spine stereotactic body radiotherapyKhaled Dibs, Joshua D Palmer, Rahul N Prasad, et al.
Neuro-Oncology|May 5, 2022
Phase III trial of chemoradiotherapy with temozolomide plus nivolumab or placebo for newly diagnosed glioblastoma with methylated MGMT promoterMichael Lim, Michael Weller, Ahmed Idbaih, et al.
Neuro-Oncology Advances|March 26, 2025
Phase 1 trial of hypofractionated stereotactic re-irradiation in combination with nivolumab, ipilimumab, and bevacizumab for recurrent high-grade gliomasSolmaz Sahebjam, Raju R Raval, Peter A Forsyth, et al.
International Journal of Radiation Oncology, Biology, Physics|August 18, 2025
Pre-Operative Versus Post-Operative Fractionated Stereotactic Radiotherapy: A Single Institution Analysis of 534 Resected MetastasesHaley K Perlow, Sarah Hennings, Jared Bradshaw, et al.
International Journal of Obesity (2005)|August 5, 2015
A novel gene THSD7A is associated with obesityS Nizamuddin, P Govindaraj, S Saxena, et al.
International Journal of Radiation Oncology, Biology, Physics|April 9, 2026
Improved progression-free survival following dose-escalated vs. standard dose post-operative radiation therapy for high-risk meningiomas: An International Multicenter Individual Patient Level Meta-Analysis (FIRESTORM)Raj Singh, Andrew Koempel, Beck French, et al.
Neurosurgery|October 18, 2022
Concurrent Administration of Immune Checkpoint Inhibitors and Stereotactic Radiosurgery Is Well-Tolerated in Patients With Melanoma Brain Metastases: An International Multicenter Study of 203 PatientsEric J Lehrer, Jason Gurewitz, Kenneth Bernstein, et al.
Journal of Neurosurgery|September 17, 2022
Imaging-defined necrosis after treatment with single-fraction stereotactic radiosurgery and immune checkpoint inhibitors and its potential association with improved outcomes in patients with brain metastases: an international multicenter study of 697 patientsEric J Lehrer, Manmeet S Ahluwalia, Jason Gurewitz, et al.
International Journal of Radiation Oncology, Biology, Physics|January 23, 2023
Concurrent Administration of Immune Checkpoint Inhibitors and Single Fraction Stereotactic Radiosurgery in Patients With Non-Small Cell Lung Cancer, Melanoma, and Renal Cell Carcinoma Brain MetastasesEric J Lehrer, Roman O Kowalchuk, Jason Gurewitz, et al.
Pageof 10